Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib for Restenosis Prevention (COREA)
NCT00292721Phase 4Completed
- Sponsor
- Seoul National University Hospital
- Start
- Aug 2004
- Primary completion
- Oct 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of celecoxib in coronary arteriosclerosis (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Late Luminal Loss at 6 months. Started Aug 2004; status: completed.
02
Drugs
celecoxib
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on NCT00292721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00292721.